Martin P. Sutter

Director, LIFECELL CORP.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Jun 2, 2026Exercised options 32,282 shares of Bioventus Inc.6
  • Jun 2, 2025Exercised options 26,493 shares of Bioventus Inc.8
  • Jun 7, 2024Exercised options 30,400 shares of Bioventus Inc.9
  • Jun 6, 2023Exercised options 16,648 shares of Bioventus Inc.10
  • Dec 22, 2022Returned to company 123,370 shares of AbioMed7
  • Nov 16, 2022Sold 141 shares at $375.56 of AbioMed11
  • Nov 16, 2022Sold 1,859 shares at $374.66 of AbioMed11
  • Nov 15, 2022Sold 867 shares at $374.92 of AbioMed11
  • Nov 15, 2022Sold 1,133 shares at $374.18 of AbioMed11
  • Aug 17, 2022Sold 20 shares at $287.44 of AbioMed12
  • Aug 17, 2022Sold 78 shares at $286.49 of AbioMed12
  • Aug 17, 2022Sold 77 shares at $285.59 of AbioMed12
  • Aug 17, 2022Sold 78 shares at $284.44 of AbioMed12
  • Aug 17, 2022Sold 205 shares at $283.51 of AbioMed12
  • Aug 17, 2022Sold 184 shares at $282.39 of AbioMed12
  • Aug 17, 2022Sold 785 shares at $281.52 of AbioMed12
  • Aug 17, 2022Sold 573 shares at $280.59 of AbioMed12
  • Aug 16, 2022Sold 82 shares at $293.44 of AbioMed12
  • Aug 16, 2022Sold 145 shares at $292.47 of AbioMed12
  • Aug 16, 2022Sold 840 shares at $291.33 of AbioMed12
  • Aug 16, 2022Sold 483 shares at $290.60 of AbioMed12
  • Aug 16, 2022Sold 114 shares at $289.63 of AbioMed12
  • Aug 16, 2022Sold 285 shares at $288.44 of AbioMed12
  • Aug 16, 2022Sold 51 shares at $287.66 of AbioMed12
  • Aug 11, 2022Shares withheld for tax 232 shares at $293.34 of AbioMed13